Drug resistant infections
Wellcome is working with the World Health Organization (WHO) to take on big challenges in global health.
The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) brings together a range of international experts to share expertise and take action to tackle the gaps in drug-resistant infections surveillance and epidemiology.
Wellcome Monitor 2020: Public perception of drug-resistant infections
This report presents the results of the fifth Wellcome Monitor. It looks at findings around the British public’s perceptions of drug-resistant infections and their use of antibiotics.
The global response to AMR: momentum, success, and critical gaps
This report gives an update on the status quo, recent developments and remaining critical gaps in the global response to antimicrobial resistance.
This report aims to guide experts, communicators and practitioners to communicate with impact, so that the public understands and supports action on drug-resistant infections.
Briefings and responses
Response to European Medicines Agencies Network Strategy to 2025
The European Medicines Agencies Network issued a draft strategy document in July 2020, setting out a proposed strategy to guide the work of the European Medicines Agency and Heads of Medicines Agencies for the period 2021-2025 . Wellcome responded to the AMR themeatic questions within this open cons